Faculty

Mark Korson, MD, is the Director of Education and Physician Support Services at VMP Genetics, providing remote consultative assistance to clinicians at 10 major academic medical centers that care for patients with proven or suspected metabolic disease. He has significant experience in creating innovative educational resources about metabolic diseases for non-genetic clinicians so that they can play more of a role in patient diagnosis and management. Additionally, he directs the Patient-Teacher Registry and Patient-Teacher Video Catalog at VMP Genetics, with the aim of ensuring that the patient voice plays a bigger role in the education of health professionals. Dr. Korson graduated in medicine from the University of Toronto and completed a pediatric residency at Toronto’s Hospital for Sick Children, followed by a genetics/metabolism fellowship at Boston’s Children's Hospital. He directed the metabolic clinics at Boston Children's Hospital until 2000 and across town at Tufts Medical Center until 2014. He co-founded and co-directs the SIMD’s North American Metabolic Academy. Regionally, he is on the board of the New England Regional Genetics Network, and as a founding board member of Rare New England, hosts the annual Rare Disease Day Speakers Series in New England and their online Medical Genetics Career Fairs.

Stephanie Sacharow, MD, is a medical geneticist at Boston Children’s Hospital. Dr. Sacharow graduated from Vanderbilt University and then from the University of Miami - Miller School of Medicine. She is board certified in Pediatrics, Medical Genetics and Medical Biochemical Genetics, and has been practicing for over 15 years. Dr. Sacharow was recruited to Boston Children’s Hospital in 2015, and is a member of the Harvard Medical School faculty. She was involved with the implementation and execution of expanded newborn screening for metabolic disease in South Florida. She is currently the medical director of the PAL clinic at Boston Children’s Hospital and the director of the Dr. Harvey Levy Program for Phenylketonuria and Related Conditions. She has been involved in research studies with a focus on autism, genomic imbalances, inborn errors of metabolism and other rare disorders.

Jodi Hoffman, MD, is Associate Professor of Pediatrics at Boston University School of Medical, Medical Director of the BU Genetic Counseling Master's Program, and practices Medical Genetics at Boston Medical Center. She received her medical degree at Albert Einstein College of Medicine in the Bronx, NY. Dr. Hoffman then completed a Pediatric residency at Yale Children's Hospital in New Haven. Dr. Hoffman's Medical Genetics training was completed at Children's Hospital of Philadelphia where she developed special interests in Jewish genetic diseases, hereditary cancer syndromes, connective tissue disorders, and the 22q11.2 deletion syndrome. Dr. Hoffman practices as a general medical geneticist and provides counseling and diagnosis regarding prenatal care, neonates, children, and adults with genetic conditions.

Susan Capasso, EdD, MS, is a licensed certified genetic counselor and Diplomate of the American Board of Medical Genetics. Since 2017, she has helped Bay Path University develop courses and establish the Masters level Genetic Counseling Program, which began in Fall 2017. Currently, she is a Professor and Associate Director of this Genetic Counseling Program at Bay Path University, and mentors students throughout their Capstone. She is also a site visitor for the New England Commission for Higher Education (NECHE) and has visited multiple colleges and universities accredited by NECHE throughout New England and in Switzerland. After receiving her doctorate in educational leadership from the University of Hartford, she held positions as Academic Dean and the Vice President of Academic Affairs/Dean of Faculty at St. Vincent’s College. Since 2008, she has also worked in the Oncology Department at St. Vincent’s Medical Center in Bridgeport, CT as a genetic counselor. Additionally, she has previously worked as a Professor at several institutions to develop online courses and programs, as well as developed summer camps with the motto “Why Not You!” for the disadvantaged to interest them in nursing and allied health careers.

Katherine Anderson, MD is a medical geneticist at the University of Vermont Medical Center, and assistant professor at the Larner College of Medicine at the University of Vermont. Her clinical interests include inborn errors of metabolism, pediatric genetics and prenatal genetic counseling; her research interests are focused on whole genome sequencing in acute unexplained illness. Dr. Anderson enjoys connecting with her patients and their families to complete the diagnostic odyssey and to develop a strategy that best supports patients in growth, development and health. Genetics is a confusing and ever-changing specialty, and she relishes the opportunity to learn with and from every patient.

Weitzman Institute Disclosure Statement

It is the policy of the Weitzman Institute to ensure that Continuing Education (CE) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners' and the public, the Weitzman Institute requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.

Faculty participating in a Weitzman Institute-sponsored activity must disclose to the planning committee and audience all financial or other relationship(s) with ineligible companies.